Post navigation Even without the support of Congress, he can do a lot with executive orders and new regulations. Will it be enough? Pfizer and its partner BioNTech have reported that that their coronavirus vaccine candidate is 90 per cent effective in phase III trials. How excited should we be about the news, and what questions remain unanswered?